Mangoceuticals, Inc., a company listed in the United States, has achieved a significant milestone with the Securities and Exchange Commission (SEC). The SEC has declared the company's Form S-1 effective as of September 5, 2024, at 4:30 P.M. This form is typically used by companies to register new securities for sale to the public, indicating that Mangoceuticals may be preparing to offer new shares. The effectiveness of the form marks a crucial step in the process, allowing the company to proceed with its offering.

Mangoceuticals, Inc., a company listed in the United States, has achieved a significant milestone with the Securities and Exchange Commission (SEC). The SEC has declared the company's Form S-1 effective as of September 5, 2024, at 4:30 P.M. This form is typically used by companies to register new securities for sale to the public, indicating that Mangoceuticals may be preparing to offer new shares. The effectiveness of the form marks a crucial step in the process, allowing the company to proceed with its offering.